Boston [US]/ Noida (Uttar Pradesh) [India], February 15: Curadev is excited to introduce CRD3874, a first-in-class allosteric small molecule STING agonist, with distinct pharmacological properties that distinguish it from agents that bind to STING's cGAMP site. An intravenous formulation of
New Delhi [India], February 14: Patient Herbert from Tanzania, suffering from non-Hodgkin lymphoma (A type of blood cancer), came to India for treatment last year. Now, After two months, with proper diagnosis of the disease and three cycles of Immunotherapy Chemo treatment in India, he is go
New Delhi [India], February 8: Health experts and leading oncologists of the country, highlighted the need for tailored interventions to address regional disparities for better management of Nasopharyngeal Carcinoma (NPC) in the country. They also urged to create relevant awareness around ri
According to a study published in Cell Reports Medicine in January, researchers at Tisch Cancer Institute showed that a certain form of chemotherapy boosts the immune system's ability to fight bladder cancer, especially when paired with immunotherapy.
Apart from eliminating a significant portion of the tumour cells, cancer therapies such as chemotherapy also produce senescent tumour cells, which are also referred to as "zombi cells." Senescent cells do not proliferate, but regrettably, they create an atmosphere that is conducive to the gr
Researchers at the University of Michigan Health Rogel Cancer Centre discovered a mechanism connected to serious gastrointestinal problems following immune-based cancer treatment.
A mechanism linked to severe gastrointestinal issues during immune-based cancer treatment has been discovered by researchers at the University of Michigan Health Rogel Cancer Centre.
They also found a way to deliver immunotherapy's cancer-killing impact without the unwelcome side effect. Th
Researchers at the University of Michigan Health Rogel Cancer Centre have discovered a mechanism that causes important gastrointestinal difficulties during immune-based cancer treatment.
According to the Brigham researchers' next-generation sequencing, changing existing cancer care standards might allow around 6,000 more patients in the United States to benefit from immunotherapy treatment each year.
A group led by scientists at The University of Texas at Austin has discovered a brand-new, bio-inspired medication that restores the capability of immune cells to combat cancer. The medication increases the effectiveness of immunotherapy and inhibits tumour growth in mice models of melanoma,
A study performed by UCLA Jonsson Comprehensive Cancer Centre researchers gave new light on why tumours that have spread to the brain from other parts of the body react to immunotherapy whereas glioblastoma, an aggressive brain cancer, does not.
The potential of artificial DNA constructs that, when used in conjunction with antibodies, tell the immune system to focus on malignant cells in particular is highlighted by a recent study.